MedLife S.A.

Report Publication Announcement • Aug 25, 2025

No. 70 / 25 August 2025

To: BUCHAREST STOCK EXCHANGE FINANCIAL SUPERVISORY AUTHORITY

ANNOUNCEMENT

According to the stipulations of ASF Regulation no. 5/2018 on issuers of financial instruments and market operations, Law no. 24/2017 on issuers of financial instruments and market operations (republished)

Report Date: 25 August 2025 Name of the issuing company: MED LIFE S.A. ("MedLife" or "the Company") Registered Office: Bucharest, 365 Calea Grivitei, district 1, Romania Telephone / Fax number: 0374 180 470 Unique Registration Code at the National Office of Trade Registry: 8422035 Order number on the Trade Registry: J1996003709402 EUID: ROONRC.J1996003709402 Subscribed and paid-in share capital: RON 132,870,492 Total number of shares: 531,481,968 (out of which 665,983 shares without voting rights and 530,815,985 shares with voting rights) Regulated market on which the issued securities are traded: Bucharest Stock Exchange, Premium Category

Important events to report:

H1 2025 Results report availability and Conference call details

Med Life S.A. informs shareholders and investors that starting 29 August 2025, 8:30 a.m. (Romania time), the H1 2025 Results report will be available on the company's website, in the Investor Relations / Reports and Presentations / Financial Reports section (https://www.medlife.ro/investor-relations/reports-andpresentations/financial-reports) and on the Bucharest Stock Exchange's website (symbol M).

The Company will hold a conference call for analysts and investors to present the financial results, on 29 August 2025, starting 4:00 p.m. (Romania time). The conference call will be held in English, and the transcript will be available afterwards, on MedLife's website, in the Investor Relations / Reports and Presentations / Financial Reports section. In order to participate to the event, please contact us at investors@medlife.ro.

______________